Page 3 - இருதய அமைப்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இருதய அமைப்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இருதய அமைப்புகள் Today - Breaking & Trending Today

Cardiovascular Systems Inc (CSII) Q3 2021 Earnings Call Transcript


Cardiovascular Systems Inc (CSII) Q3 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Cardiovascular Systems Inc (NASDAQ: CSII)
Popular Searches
Operator
Good day, and thank you for standing by. Welcome to Cardiovascular Systems, Inc. Fiscal Year 2021 Third Quarter Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Jack Nielsen, Vice President, Investor Relations. Please go ahead.SPONSORED:
10 stocks we like better than Cardiovascular Systems
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Mike Matson , Zilient Guidewires , Danielle Antalffy Leerink , Jack Nielsen , Rhondaj Robb , Rhonda Robb , Suraj Kalia , Ryand Egeland , Suraj Kalia Oppenheimer , Johne Nielsen , Ryan Egeland , Scott Ward , Danielle Antalffy , Cardiovascular Systems Inc , Welcome To Cardiovascular Systems Inc , Motley Fool Cardiovascular Systems Inc , Joseph Stokes Needham Company Analyst , Health Canada , Investor Relations Corporate Communications , Call Transcript , Motley Fool Logo , Systems Inc , Cardiovascular Systems , Fiscal Year , Quarter Earnings Conference ,

LivaNova (LIVN) Receives a Hold from Needham


Markets
Needham analyst Michael Matson maintained a Hold rating on LivaNova (LIVN – Research Report) today. The company’s shares closed last Wednesday at $87.05.
According to TipRanks.com, Matson is a 5-star analyst with an average return of 17.3% and a 72.0% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings.
LivaNova has an analyst consensus of Moderate Buy, with a price target consensus of $88.00.
LivaNova’s market cap is currently $4.03B and has a P/E ratio of -11.60. The company has a Price to Book ratio of -16.65.
Based on the recent corporate insider activity of 109 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LIVN in relation to earlier this year. ....

United Kingdom , City Of , Michael Matson , Zimmer Biomet Holdings , Livanova Plc , Research Report , Axonics Modulation Technologies , Cardiovascular Systems , Zimmer Biomet , Moderate Buy , Nova Plc , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , மைக்கேல் மேட்சன் , ஸிம்மர் பயோமெட் ஹோல்டிங்ஸ் , ஆராய்ச்சி அறிக்கை , இருதய அமைப்புகள் , ஸிம்மர் பயோமெட் , மிதமான வாங்க , நோவா ப்ல் ,